|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
22.100 +0.250 (+1.144%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 2,804,765 | -7.891% | 3,045,060 | 3,195,646 | 3,224,555 | 2,039,329 |
| Land & other Lease Assets | 442,405 | 88.528% | 234,663 | 254,247 | 250,840 | 264,489 |
| Intangible Assets | 245,286 | 38.255% | 177,416 | 33,422 | 17,037 | 9,893 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 241,071 | 0 | 0 |
| Other Non-current Assets | 723,598 | 3.573% | 698,633 | 445,873 | 488,371 | 1,192,360 |
| 4,216,054 | 1.451% | 4,155,772 | 4,170,259 | 3,980,803 | 3,506,071 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 651,224 | 13.103% | 575,782 | 447,890 | 410,127 | 298,727 | |
| Trade Receivables | 3,169,763 | -1.384% | 3,214,251 | 3,578,392 | 3,675,990 | 3,127,460 | |
| Cash & Bank Balances | 22,621,566 | 0.833% | 22,434,691 | 17,615,274 | 14,702,056 | 4,284,970 | |
| Other Current Assets | 999,242 | -62.414% | 2,658,583 | 4,190,064 | 4,391,195 | 9,574,832 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 27,441,795 | -4.991% | 28,883,307 | 25,831,620 | 23,179,368 | 17,285,989 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 217,851 | 33.028% | 163,763 | 222,296 | 248,330 | 124,382 | ||
| S-T Debt & Leases | 56,880 | -98.645% | 4,199,285 | 15,543 | 9,968 | 11,039 | ||
| Other Current Liabilities | 2,420,487 | -3.173% | 2,499,801 | 2,381,663 | 2,765,432 | 2,554,118 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 2,695,218 | -60.727% | 6,862,849 | 2,619,502 | 3,023,730 | 2,689,539 | |||
| Net Current Assets | 24,746,577 | 12.380% | 22,020,458 | 23,212,118 | 20,155,638 | 14,596,450 | ||
| Total Assets Less Current Liabilities | 28,962,631 | 10.645% | 26,176,230 | 27,382,377 | 24,136,441 | 18,102,521 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 61,013 | -41.586% | 104,450 | 4,362,313 | 3,817,913 | 81,710 | |||
| Other Non-current Liabilities | 221,704 | -19.964% | 277,007 | 373,120 | 289,683 | 145,213 | |||
| 282,717 | -25.885% | 381,457 | 4,735,433 | 4,107,596 | 226,923 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 52 | 0.000% | 52 | 52 | 52 | 52 | ||||
| Reserves | 28,679,862 | 11.185% | 25,794,721 | 22,646,892 | 20,028,793 | 17,875,546 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 28,679,914 | 11.185% | 25,794,773 | 22,646,944 | 20,028,845 | 17,875,598 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 28,679,914 | 11.185% | 25,794,773 | 22,646,944 | 20,028,845 | 17,875,598 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 80,445 | 39,341 | 202,836 | 339,900 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 17/04/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,371,825 |
| %Change | 33.389% |
| EPS / (LPS) | RMB 0.740 |
| NBV Per Share (¥) | RMB 4.832 |